Compare RNXT & USIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RNXT | USIO |
|---|---|---|
| Founded | 2012 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.0M | 42.2M |
| IPO Year | 2021 | 1999 |
| Metric | RNXT | USIO |
|---|---|---|
| Price | $0.89 | $1.49 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $8.25 | $4.00 |
| AVG Volume (30 Days) | ★ 311.0K | 107.8K |
| Earning Date | 05-14-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 20.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $1,123,000.00 | ★ $28,200,535.00 |
| Revenue This Year | $194.66 | $12.15 |
| Revenue Next Year | $279.78 | $8.57 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 2511.63 | 12.69 |
| 52 Week Low | $0.70 | $1.03 |
| 52 Week High | $1.45 | $2.02 |
| Indicator | RNXT | USIO |
|---|---|---|
| Relative Strength Index (RSI) | 48.40 | 52.67 |
| Support Level | $0.89 | $1.35 |
| Resistance Level | $1.07 | $1.58 |
| Average True Range (ATR) | 0.07 | 0.11 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 54.09 | 28.36 |
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
Usio Inc is a cloud-based Fintech payment processor. The company serves multiple industry verticals with technology that facilitates payment acceptance and funds disbursement in a single, full-stack ecosystem. It provides payment acceptance through multiple payment methods, including payment facilitation, prepaid card, and electronic billing products and services to businesses, merchants, and consumers. The company's reportable operating segments are Output Solutions and Merchant Services, and these segments.